{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-21-013474","form_type":"8-K","ticker":"VSTM","cik":"0001526119","company_name":"Verastem, Inc.","filed_at":"2021-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.858049+00:00","generated_at":"2026-06-28T17:58:55.701586+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Verastem appoints Michelle Robertson to Board, replacing Gina Consylman effective Nov 15, 2021","bullets":["Michelle Robertson appointed as Class III director and audit committee chair, effective Nov 15, 2021.","Gina Consylman resigned from Board and audit committee, effective same date, to focus on other duties.","Robertson is CFO of Editas Medicine; previously CFO of Momenta Pharmaceuticals through J&J acquisition.","Robertson receives stock option grant of 63,493 shares upon joining, plus standard director compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-21-013474","json":"https://secwatch.observer/filing/0001558370-21-013474.json","markdown":"https://secwatch.observer/filing/0001558370-21-013474.md","text":"https://secwatch.observer/filing/0001558370-21-013474.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/0001558370-21-013474-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/vstm-20211021x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T17:58:55.701586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19575aad85","claim":"Michelle Robertson was elected as Class III Director and Audit Committee Chair at Verastem, Inc..","evidence_excerpt":"On October 22, 2021, the Board unanimously voted to elect Ms. Michelle Robertson as a Class III director of the Company and to serve on the audit committee of the Board as chairperson, effective November 15, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/0001558370-21-013474-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class III Director and Audit Committee Chair"}],"fact_type":"executive_change"},{"claim_id":"5d46ac992c","claim":"Gina Consylman resigned as Director at Verastem, Inc..","evidence_excerpt":"On October 21, 2021, Gina Consylman resigned from the Board and its audit committee, effective November 15, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/0001558370-21-013474-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}